US Pharma Peers Into The Unknown
Despite many bumps in the road and a lack of clear direction, the US healthcare ecosystem always finds a way to deliver its goal – improving the health and well-being of every American. With political, policy and funding uncertainty – and mounting pressures on the US healthcare system to deliver improved outcomes and reduce costs – all stakeholders and contributors are facing significant challenges. We spoke to speaker John Bardi, VP, Public Affairs, Otsuka about the future of market access and reimbursement in the US.
Trends in real-world evidence: Unlocking the data
The ‘evidence revolution’ currently taking place in pharma has the potential to leave an unprecedented impact on the healthcare system worldwide. How best to keep-up, adapt and make the most of the great range of opportunities being presented is now at the heart of how many companies are planning for the future.
For more information on how real-world evidence impacts each part of the drug life cycle, full case studies from tech innovators and an in depth interview with ex-commissioner of the FDA – download your copy today!
Download your copy here